Skip to content

Raltegravir

Isentress, Isentress Hd (raltegravir) is a small molecule pharmaceutical. Raltegravir was first approved as Isentress on 2007-10-12. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Isentress's patents are valid until 2032-03-30 (FDA).
Trade Name Isentress
Common Name Raltegravir
Indication hiv infections
Drug Class Antivirals: integrase inhibitors
Raltegravir
Get full access now